NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...

(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...

Ziftomenib (Komzifti; Kura Oncology and Kyowa Kirin), an oral, once-daily, selective menin inhibitor, has received approval from the FDA for the treatment of adult patients with relapsed or refractory ...

European Commission grants conditional marketing approval for Roche’s Lunsumio subcutaneous for R/R follicular lymphoma: Basel Thursday, November 20, 2025, 12:00 Hrs [IST] Roche ...

De De Pyaar De 2 brings back Ajay Devgn and Rakul Preet Singh in a light, above-average comedy, but it's R Madhavan and ...

"Calamos is driving the autocallable income revolution in the ETF marketplace, as demonstrated by the success of CAIE and now the launch of CAIQ. Building the definitive Autocallable ETF franchise is ...

The potential starter pit at the Santa Barbara zone continues to be open laterally and downdip with definition drilling ...

Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

Ravichandran Ashwin exposed India batters' lack of quality to battle ball tweakers by claiming that if legendary batter ...

The R.A.D ONE V2 is the all-round gym shoe that’s good at everything, and ready for anything. Cushioned for plyometrics, ...

The peppy, bygone “Lone Ranger” anthem is delightfully off-key, and yet, most people make a U-turn and enjoy the botched ...

Animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 1996). The protocol (AR2300) ...